Page last updated: 2024-09-05

latrepirdine and Cognition Disorders

latrepirdine has been researched along with Cognition Disorders in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benhamú, B; López-Rodríguez, ML; Martín-Fontecha, M; Pardo, L; Vázquez-Villa, H	1
Cano-Cuenca, N; Jordán, J; Solís-García del Pozo, JE	1
Buccafusco, JJ; Lee, CH; Mohler, EG; Terry, AV; Webster, SJ; Wilson, CA	1
Beniashvili, AG; Lepilkina, TA; Morozova, MA; Rupchev, GE	1

Reviews

2 review(s) available for latrepirdine and Cognition Disorders

Article	Year
Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease. Journal of medicinal chemistry, 2014, Sep-11, Volume: 57, Issue:17 Topics: Alzheimer Disease; Binding Sites; Clinical Trials as Topic; Cognition Disorders; Humans; Models, Molecular; Molecular Structure; Protein Structure, Tertiary; Receptors, Serotonin; Serotonin Antagonists	2014
Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis. Journal of Alzheimer's disease : JAD, 2014, Volume: 38, Issue:1 Topics: Alzheimer Disease; Antipsychotic Agents; Cognition Disorders; Humans; Huntington Disease; Indoles; MEDLINE; Neuropsychological Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia	2014

Article

Year

Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

Journal of medicinal chemistry, 2014, Sep-11, Volume: 57, Issue:17

Topics: Alzheimer Disease; Binding Sites; Clinical Trials as Topic; Cognition Disorders; Humans; Models, Molecular; Molecular Structure; Protein Structure, Tertiary; Receptors, Serotonin; Serotonin Antagonists

2014

Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis.

Journal of Alzheimer's disease : JAD, 2014, Volume: 38, Issue:1

Topics: Alzheimer Disease; Antipsychotic Agents; Cognition Disorders; Humans; Huntington Disease; Indoles; MEDLINE; Neuropsychological Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia

2014

Trials

1 trial(s) available for latrepirdine and Cognition Disorders

Article	Year
Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission. Psychiatria Danubina, 2012, Volume: 24, Issue:2 Topics: Acute Disease; Adult; Antipsychotic Agents; Cognition Disorders; Drug Therapy, Combination; Humans; Indoles; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Risperidone; Schizophrenia, Paranoid; Severity of Illness Index	2012

Article

Year

Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission.

Psychiatria Danubina, 2012, Volume: 24, Issue:2

Topics: Acute Disease; Adult; Antipsychotic Agents; Cognition Disorders; Drug Therapy, Combination; Humans; Indoles; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Risperidone; Schizophrenia, Paranoid; Severity of Illness Index

2012

Other Studies

1 other study(ies) available for latrepirdine and Cognition Disorders

Article	Year
The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British journal of pharmacology, 2011, Volume: 164, Issue:3 Topics: Age Factors; Alzheimer Disease; Animals; Cognition Disorders; Female; Indoles; Macaca mulatta; Male; Memory, Short-Term; Psychomotor Performance; Scopolamine	2011